Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
FFNTF Stock Summary
Top 10 Correlated ETFs
FFNTF
In the News
An Unvarnished Look At New York + California Cannabis Markets
An Unvarnished Look At New York + California Cannabis Markets
Top Marijuana Penny Stocks for January
Let's take a look at this week's most promising marijuana penny stocks. The US cannabis industry is buzzing with potential, despite the twists and turns of regulatory changes. These stocks, often priced under $5, attract investors with their affordability and potential for rapid growth. However, remember, with great potential comes greater risk. These stocks can be quite volatile, and their lower trading volumes mean they can move sharply on market news.
4Front Ventures Corp. (FFNTF) Q3 2023 Earnings Call Transcript
4Front Ventures Corp. (OTCQX:FFNTF) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ET Company Participants Leo Gontmakher - Chief Executive Officer Brandon Mills - President, Illinois and Massachusetts Operations Andrew Thut - Chief Investment Officer Karl Chowscano - Consulting President Brian Ehmke - Director of Finance Ray Landgraf - President, Corporate Development Conference Call Participants Neal Gilmer - Haywood Securities Yewon Kang - Canaccord Genuity Jesse Redmond - Water Tower Research Operator Good afternoon and welcome to the 4Front Ventures Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.
4Front Ventures Announces Revised Third Quarter 2023 Results and Conference Call Date of November 20, 2023 at 5:00 PM ET
PHOENIX, Ariz. , Nov. 13, 2023 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated multi-state cannabis operator and retailer, today announced that it is rescheduling the release of its third quarter 2023 results and conference call due to delays related to the Company's audit.
4Front Ventures Corp. (FFNTF) Q2 2023 Earnings Call Transcript
4Front Ventures Corp. (OTCQX:FFNTF) Q2 2023 Earnings Conference Call August 15, 2023 5:00 PM ET Company Participants Leo Gontmakher - Chief Executive Officer Andrew Thut - Chief Investment Officer Karl Chowscano - Consulting President Ray Landgraf - President, California Operations Brian Ehmke - Director of Finance Conference Call Participants Neal Gilmer - Haywood Securities Yewon Kang - Canaccord Genuity Operator Good afternoon and welcome to the 4Front Ventures Second Quarter 2023 Earnings Conference Call. Today's call is being recorded.
These Marijuana Stocks Are Ready To Run In 2023
Marijuana stocks may be on their way to seeing an increase in trading momentum. At least for some as cannabis companies are preparing to report earnings. When a company can show profitability or any kind of progress it can lead to a recovery. As well when one company begins to do well it can also impact how other cannabis stocks trade due to speculation. Right now there is a fair amount of speculative buying mainly due to what people believe will happen in the future.
Blazing Opportunities: Top Marijuana Stocks To Watch On End Of July
As the cannabis industry and top marijuana stocks continue to rise, 2023 is an excellent opportunity for investors and traders to enter the thriving world of cannabis companies. With new markets opening up, regulatory environments changing, and consumer demand increasing, the prospect of short-term rewards is enticing. However, trading well in this volatile sector necessitates a cautious approach, including utilizing technical indicators, applying appropriate risk management, and completing extensive research on industry catalysts.
3 Top Marijuana Stocks To Watch This Week
Marijuana stock investors are keeping watch for the next investment opportunity. With the current wave of volatile trading, the end result every investor wants to see is a rise in trading. Yet this volatile action has impacted the cannabis sector for some time now. This has left many shareholders in a place where they need to be quick enough to take profits when there is a bounce. But when there is a recovery most times companies have not been able to sustain that momentum.
2 Marijuana Penny Stocks To Watch This Week
Marijuana stocks have seen modest gains as the market has gained traction. Many marijuana penny stocks have seen significant percentage gains. In May, bipartisan US House and Senate senators revived the SAFE Banking Act, revitalizing the cannabis sector. Cannabis penny stocks are one sector where new investors may see short-term gains. A penny stock is one that is worth less than $5 per share. Despite the industry's well-known high level of market volatility, short-term investors could make significant profits.
4Front Ventures: Cash Flow Break-Even Probably Only KPI That Matters
4Front Ventures' Brandon Mills discusses how they're making it work in an incredibly challenging environment. Multitude of headwinds hitting cannabis industry.
FFNTF Financial details
FFNTF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-04-30 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.1 | 0.07 | 0.11 | 0.18 | 0.19 | |
Net income per share | -0.08 | -0.43 | -0.12 | -0.06 | -0.07 | |
Operating cash flow per share | 0 | -0.06 | -0.03 | 0.01 | 0.01 | |
Free cash flow per share | 0 | -0.11 | -0.05 | -0.01 | 0.01 | |
Cash per share | 0.3 | 0.01 | 0.04 | 0.04 | 0.02 | |
Book value per share | 0.79 | 0.18 | 0.08 | 0.07 | 0.04 | |
Tangible book value per share | 0.79 | 0 | -0.02 | -0.01 | -0.09 | |
Share holders equity per share | 0.79 | 0.18 | 0.08 | 0.07 | 0.04 | |
Interest debt per share | 0.2 | 0.28 | 0.26 | 0.31 | 0.38 | |
Market cap | 34.97M | 189.14M | 473.71M | 596.91M | 147.79M | |
Enterprise value | 30.53M | 294.48M | 575.25M | 742.22M | 357.43M | |
P/E ratio | -11.58 | -1.05 | -7.9 | -17.09 | -3.15 | |
Price to sales ratio | 8.62 | 6.08 | 8.22 | 5.71 | 1.25 | |
POCF ratio | 0 | -7.56 | -33.74 | 103.33 | 16.86 | |
PFCF ratio | 0 | -3.94 | -16.97 | -73.74 | 23.33 | |
P/B Ratio | 1.13 | 2.48 | 11.24 | 14.62 | 5.23 | |
PTB ratio | 1.13 | 2.48 | 11.24 | 14.62 | 5.23 | |
EV to sales | 7.53 | 9.46 | 9.98 | 7.1 | 3.01 | |
Enterprise value over EBITDA | -23.63 | -11.18 | -88.8 | -82.72 | -42.56 | |
EV to operating cash flow | 0 | -11.77 | -40.97 | 128.48 | 40.77 | |
EV to free cash flow | 0 | -6.13 | -20.61 | -91.69 | 56.43 | |
Earnings yield | -0.09 | -0.96 | -0.13 | -0.06 | -0.32 | |
Free cash flow yield | 0 | -0.25 | -0.06 | -0.01 | 0.04 | |
Debt to equity | 0.24 | 1.46 | 2.86 | 4.11 | 7.96 | |
Debt to assets | 0.16 | 0.54 | 0.59 | 0.66 | 0.65 | |
Net debt to EBITDA | 3.43 | -4 | -15.67 | -16.19 | -24.96 | |
Current ratio | 1.44 | 1.68 | 1.18 | 1.02 | 0.69 | |
Interest coverage | -2.47 | -5.32 | -1.05 | -1.03 | -1.96 | |
Income quality | 0 | 0.14 | 0.3 | -0.15 | -0.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.99 | 0.99 | 0.45 | 0.36 | 0.33 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.37 | 0.25 | 0.19 | 0.25 | |
Capex to operating cash flow | 0 | 0.92 | 0.99 | -2.4 | -0.28 | |
Capex to revenue | 0 | -0.74 | -0.24 | -0.13 | -0.02 | |
Capex to depreciation | 0 | -4.48 | -1.62 | -2.09 | -0.29 | |
Stock based compensation to revenue | 0 | 0.19 | 0.09 | 0.1 | 0.06 | |
Graham number | 1.16 | 1.32 | 0.46 | 0.3 | 0.27 | |
ROIC | -0.05 | -0.17 | -0.1 | -0.07 | -0.08 | |
Return on tangible assets | -0.06 | -1.41 | -0.39 | -0.17 | -0.18 | |
Graham Net | -0.07 | -0.25 | -0.25 | -0.3 | -0.44 | |
Working capital | 4.27M | 12.89M | 6.95M | 1.11M | -24.18M | |
Tangible asset value | 31.03M | 549K | -9.74M | -8.5M | -56.53M | |
Net current asset value | -2.19M | -96.2M | -117.82M | -163.81M | -263.11M | |
Invested capital | 0.24 | 1.46 | 2.86 | 4.11 | 7.96 | |
Average receivables | 874.77K | 7.08M | 8.96M | 5.7M | 8.59M | |
Average payables | 1.09M | 5.08M | 6.43M | 3.42M | 7.41M | |
Average inventory | 73.85K | 5.74M | 14.68M | 19.09M | 22.86M | |
Days sales outstanding | 156.58 | 145.75 | 34.78 | 20.63 | 34.72 | |
Days payables outstanding | 0 | 173.61 | 81.59 | 13.97 | 59.87 | |
Days of inventory on hand | 0 | 241.61 | 311.66 | 133.21 | 120.65 | |
Receivables turnover | 2.33 | 2.5 | 10.49 | 17.69 | 10.51 | |
Payables turnover | 0 | 2.1 | 4.47 | 26.13 | 6.1 | |
Inventory turnover | 0 | 1.51 | 1.17 | 2.74 | 3.03 | |
ROE | -0.1 | -2.37 | -1.42 | -0.86 | -1.66 | |
Capex per share | 0 | -0.05 | -0.03 | -0.02 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Net income per share | -0.01 | -0.04 | -0.02 | -0.02 | -0.1 | |
Operating cash flow per share | 0 | 0.02 | -0.01 | 0 | 0 | |
Free cash flow per share | 0 | 0.02 | -0.01 | 0 | 0 | |
Cash per share | 0.01 | 0.02 | 0.01 | 0.01 | 0 | |
Book value per share | 0.08 | 0.04 | 0.03 | 0.01 | -0.08 | |
Tangible book value per share | -0.07 | -0.09 | -0.1 | -0.12 | -0.18 | |
Share holders equity per share | 0.08 | 0.04 | 0.03 | 0.01 | -0.08 | |
Interest debt per share | 0.3 | 0.36 | 0.36 | 0.35 | 0.32 | |
Market cap | 207.17M | 147.79M | 114.62M | 100.82M | 163.27M | |
Enterprise value | 390.15M | 357.43M | 334.82M | 321.18M | 368.4M | |
P/E ratio | -6.02 | -1.43 | -2.52 | -2.2 | -0.66 | |
Price to sales ratio | 6.38 | 4.67 | 3.77 | 3.28 | 7.1 | |
POCF ratio | 228.92 | 13.75 | -16.65 | 37.51 | 1.31K | |
PFCF ratio | 334.69 | 11.13 | -16.25 | 42.04 | 513.43 | |
P/B Ratio | 4.21 | 5.23 | 6.41 | 13.05 | -3.22 | |
PTB ratio | 4.21 | 5.23 | 6.41 | 13.05 | -3.22 | |
EV to sales | 12.01 | 11.31 | 11.02 | 10.46 | 16.02 | |
Enterprise value over EBITDA | 422.7 | -45.4 | -78.65 | -81.64 | -48.11 | |
EV to operating cash flow | 431.11 | 33.26 | -48.64 | 119.49 | 2.95K | |
EV to free cash flow | 630.29 | 26.92 | -47.46 | 133.93 | 1.16K | |
Earnings yield | -0.04 | -0.17 | -0.1 | -0.11 | -0.38 | |
Free cash flow yield | 0 | 0.09 | -0.06 | 0.02 | 0 | |
Debt to equity | 3.83 | 7.96 | 12.57 | 29.23 | -4.1 | |
Debt to assets | 0.59 | 0.65 | 0.67 | 0.68 | 0.77 | |
Net debt to EBITDA | 198.24 | -26.63 | -51.73 | -56.01 | -26.79 | |
Current ratio | 0.74 | 0.69 | 0.61 | 0.58 | 0.34 | |
Interest coverage | -0.3 | -8.87 | -1.81 | -1.88 | -4.23 | |
Income quality | -0.11 | -0.42 | 0.6 | -0.23 | -0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.25 | 0.48 | 0.29 | 0.25 | 0.67 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.3 | 0.25 | 0.25 | 0.25 | 0.26 | |
Capex to operating cash flow | -0.32 | 0.24 | 0.02 | -0.11 | 1.54 | |
Capex to revenue | -0.01 | 0.08 | -0.01 | -0.01 | 0.01 | |
Capex to depreciation | -0.13 | 1.69 | -0.07 | -0.12 | -0.29 | |
Stock based compensation to revenue | 0.03 | 0.16 | 0.03 | 0.01 | 0.16 | |
Graham number | 0.15 | 0.2 | 0.11 | 0.07 | 0.41 | |
ROIC | -0.01 | -0.06 | -0.02 | -0.02 | -0.04 | |
Return on tangible assets | -0.04 | -0.1 | -0.05 | -0.05 | -0.31 | |
Graham Net | -0.38 | -0.44 | -0.45 | -0.45 | -0.46 | |
Working capital | -18M | -24.18M | -28.96M | -33.77M | -64.19M | |
Tangible asset value | -46.58M | -56.53M | -66.21M | -75.63M | -119.75M | |
Net current asset value | -219.62M | -263.11M | -269.7M | -275.24M | -286.11M | |
Invested capital | 3.83 | 7.96 | 12.57 | 29.23 | -4.1 | |
Average receivables | 10.89M | 11.89M | 11.91M | 13.41M | 11.33M | |
Average payables | 8.85M | 12M | 12.37M | 13.39M | 13.51M | |
Average inventory | 29.89M | 28.26M | 26.49M | 26.38M | 21.26M | |
Days sales outstanding | 34.66 | 32.1 | 37.15 | 41.89 | 32.77 | |
Days payables outstanding | 58.37 | 36.54 | 55.93 | 62.8 | 80.71 | |
Days of inventory on hand | 159.77 | 73.63 | 127.14 | 108.19 | 112.56 | |
Receivables turnover | 2.6 | 2.8 | 2.42 | 2.15 | 2.75 | |
Payables turnover | 1.54 | 2.46 | 1.61 | 1.43 | 1.12 | |
Inventory turnover | 0.56 | 1.22 | 0.71 | 0.83 | 0.8 | |
ROE | -0.17 | -0.91 | -0.64 | -1.49 | 1.22 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
FFNTF Frequently Asked Questions
What is 4Front Ventures Corp. stock symbol ?
4Front Ventures Corp. is a US stock , located in Phoenix of Az and trading under the symbol FFNTF
What is 4Front Ventures Corp. stock quote today ?
4Front Ventures Corp. stock price is $0.112 today.
Is 4Front Ventures Corp. stock public?
Yes, 4Front Ventures Corp. is a publicly traded company.